tirzepatide cost vs semaglutide and liraglutide for weight loss in patients with overweight or obesity without diabetes: A short-term cost-effectiveness analysis in the United States The 2026 Brandon GLP-1 Report:

Javaheri S, Barbe F, Campos-Rodriguez F, Dempsey JA, Khayat R, Javaheri S, et al

On the rise From 2020 to 2023, scientists saw a rapid rise in the number of young adults who receive GLP-1 drugs

Chung YW, Lee JY, Ju HH, Choi JA

For patients using insulin or sulfonylureas, proactive dose reduction of these medications should be considered before tirzepatide escalation to mitigate hypoglycemia risk, with increased glucose monitoring during the transition

Gene delivery by replication-deficient recombinant adenoviruses (AdVs) in the study of Cu, Zn superoxide dismutase type 1 (SOD)-linked familial amyotrophic lateral sclerosis (FALS)